Janssen Rheumatology
For US Healthcare Providers and Medical Professionals. Global Trial Finder. Medical Inquiries and MSL Locator. IIS Portal.
Johnson & Johnson Rheumatology Newsroom
Nearly 240 million people worldwide suffer from severe autoantibody diseases, many without safe, effective treatments. Our approach to targeting ...
Johnson & Johnson showcases innovation and leadership in ...
... Rheumatology (EULAR) 2024 Congress (Vienna, Austria, June 12-15). Among the accepted data, 21 abstracts and presentations will feature ...
Our Commitment to Rheumatology | Janssen
At Janssen Immunology, we are relentlessly driven to make a difference in the lives of patients and families impacted by immune-mediated ...
Psoriatic arthritis (PsA) - Johnson & Johnson Innovative Medicine
Johnson & Johnson Innovative Medicine is at the forefront of new treatment development in rheumatic diseases, beginning with the development ...
About Janssen Biotech, Inc. | STELARA® (ustekinumab)
janssenbiotech.com. Discover the immunological conditions that Janssen Immunology has expertise in treating, which include rheumatology,. WHAT IS STELARA ...
About Dr. Janssen - Namieta Janssen MD
Board Certified Rheumatologist ... Dr. Janssen grew up in the Houston area and is pleased to call Houston home. She attended the University of Texas as an ...
Janssen Highlights Data from Rheumatology Portfolio During the ...
Thirty-five abstracts with clinical trial data to be presented, featuring findings across psoriatic arthritis (PsA), rheumatoid arthritis (RA) and systemic ...
Phase 2 Nipocalimab Data Establish Proof of Mechanism in Adults ...
... rheumatoid arthritis,” said Terence Rooney, M.D., Vice President, Rheumatology Disease Area Leader, Janssen. “Current treatments, like TNF ...
Namieta Janssen MD – Board Certified Rheumatologist
Welcome to Dr. Janssen's Office! · See Our Facebook Feed ...
TREMFYA® (guselkumab) Provides Sustained Improvements ...
... Rheumatology (EULAR) meeting taking place in Milan, Italy, May 31 ... None of the Janssen Pharmaceutical Companies nor Johnson & Johnson ...
Erin Margaret Janssen MD, PhD - CS Mott Children's Hospital
Erin Janssen, MD, PhD is the Director of the Division of Pediatric Rheumatology at the C.S. Mott Children's Hospital. Dr. Janssen earned her doctorate in ...
Rheumatoid Arthritis - Our Medicines | Janssen Australia
Janssen Australia > Our Medicines · Janssen Medicines in Australia · REMICADE® · Ankylosing spondylitis, Crohn's Disease, Plaque Psoriasis, Psoriatic Arthritis, ...
Erin Margaret Janssen MD, PhD - University of Michigan Health
Consent for Cookie Use We use cookies to improve your experience on our websites. You can learn more about what information we collect and how we use it on ...
Rheumatoid Arthritis Treatment | SIMPONI® (golimumab)
So talk to your doctor about treatment options and what might be right for you. Janssen CarePath Savings Program for SIMPONI®. Eligible patients using ...
Dr. Erin M. Janssen, MD | Ann Arbor, MI | Pediatric Rheumatologist
Dr. Erin M. Janssen is a Pediatric Rheumatologist in Ann Arbor, MI. Find Dr. Janssen's phone number, address, insurance information, hospital affiliations ...
SIMPONI® Letter of Exception (Rheumatology). Letter of Exception (Rheumatology). A template that you can fill out and submit to a patient's health insurance ...
Congress of Clinical Rheumatology (CCR West 2024)
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress ...
The Janssen Pharmaceutical Companies of Johnson & Johnson's Post
New real-world study findings published in Rheumatology and Therapy showed improved psoriatic arthritis (PsA) disease activity across joints ...
Janssen's antibody drug shows phase 2 potential in rheumatoid ...
The proof-of-concept trial, dubbed IRIS-RA, is the first to investigate a treatment for rheumatoid arthritis that blocks a protein called ...